Hosted on MSN1mon
SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142“I am particularly excited with the analysis of the results of our Phase 1 trial, as it marks the successful achievement of another critical milestone for SAB-142,” stated Samuel J ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results